"Osteoarthritis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
| Descriptor ID |
D010003
|
| MeSH Number(s) |
C05.550.114.606 C05.799.613
|
| Concept/Terms |
Osteoarthritis- Osteoarthritis
- Osteoarthritides
- Osteoarthrosis
- Osteoarthroses
- Arthritis, Degenerative
- Arthritides, Degenerative
- Degenerative Arthritides
- Degenerative Arthritis
|
Below are MeSH descriptors whose meaning is more general than "Osteoarthritis".
Below are MeSH descriptors whose meaning is more specific than "Osteoarthritis".
This graph shows the total number of publications written about "Osteoarthritis" by people in this website by year, and whether "Osteoarthritis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 1 | 3 |
| 2016 | 2 | 2 | 4 |
| 2017 | 23 | 13 | 36 |
| 2018 | 27 | 4 | 31 |
| 2019 | 12 | 2 | 14 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Osteoarthritis" by people in Profiles.
-
Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19. Arthritis Rheumatol. 2021 05; 73(5):731-739.
-
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis. 2021 07; 80(7):943-951.
-
Returning to operating following COVID-19 shutdown: what can human factors tell us? Bone Joint J. 2020 10; 102-B(10):1277-1278.
-
Tackling osteoarthritis during COVID-19 pandemic. Ann Rheum Dis. 2021 02; 80(2):151-153.
-
Synthesis of N,N'-bis(1,5-dimethyl-2-phenyl-1,2-dihydro-3-oxopyrazol-4-yl) sebacamide that ameliorate osteoarthritis symptoms and improve bone marrow matrix structure and cartilage alterations induced by monoiodoacetate in the rat model: "Suggested potent anti-inflammatory agent against COVID-19". Hum Exp Toxicol. 2021 Feb; 40(2):325-341.
-
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials. Travel Med Infect Dis. 2020 Jul - Aug; 36:101812.
-
Management of Osteoarthritis During the COVID-19 Pandemic. Clin Pharmacol Ther. 2020 10; 108(4):719-729.
-
Comorbidities in Osteoarthritis: A Systematic Review and Meta-Analysis of Observational Studies. Arthritis Care Res (Hoboken). 2020 07; 72(7):991-1000.
-
Post-radiosynovectomy imaging utilizing Erbium-169 citrate. Appl Radiat Isot. 2019 Dec; 154:108853.
-
Advances in Molecular biomarker for early diagnosis of Osteoarthritis. Biomol Concepts. 2019 Aug 09; 10(1):111-119.